BioSpace News Archive

Drug Development

Arecor announces Phase 1 of AT247 at ADA

AT247 delivers significantly accelerated absorption of insulin compared to best in class treatments NovoRapid® and Fiasp®

June 15, 2020
·
4 min read
Business

Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer

Aridis Pharmaceuticals, Inc. announced that it has appointed Dr. Hasan Jafri as Chief Medical Officer. Dr. Jafri replaces Dr. Paul Mendelman who has been serving as the Company’s interim CMO since October, 2019 and will transition to the role of senior medical advisor to the Company.

June 15, 2020
·
7 min read
MolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO

Leading GPO Accepts MolecuLight i:X Point-of-Care Device for Detection of Bacteria and Digital Wound Measurement for its National Membership

June 15, 2020
·
4 min read
Genetown

Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies

MGTA-117 conditioning for precise depletion of cells in the bone marrow could potentially increase patients’ benefit from Beam’s base editing therapies for sickle cell disease and beta thalassemia

June 15, 2020
·
10 min read
Drug Development

Xeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk of Hypoglycemia During and After Aerobic Exercise

Results show a pre-treatment with a micro dose (150 µg) of Gvoke RTU Micro significantly prevented Exercise-Induced Hypoglycemia (EIH) during prolonged, moderate-to-high intensity aerobic exercise in a real-world setting with or without adjustment to insulin

June 15, 2020
·
10 min read
Drug Development

Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Partner, Kaken Pharmaceutical

Data based on registration study in Japan of sofpironium bromide gel, 5% in patients with primary axillary hyperhidrosis

June 15, 2020
·
7 min read
Bio NC

medi® USA introduces its newest flat-knit option with the mediven® cosy 450

Medical device manufacturer medi® USA announced the launch of its newest addition to its flat-knit compression portfolio with the new mediven® cosy 450 – a product range offering flexible freedom of movement with strong wall stability.

June 15, 2020
·
2 min read
Business

3M Reports Sales Information for Month of May 2020

Total sales for May declined 20 percent year-on-year to $2.2 billion. Organic local-currency sales declined 21 percent while acquisitions, net of divestitures, increased sales by 2 percent.

June 15, 2020
·
4 min read
BioMidwest

Myriad Announces New Favorable Coverage Policies for Prolaris® from Three New Commercial Health Plans Including Major National Provider

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that the company has received favorable coverage decisions for Prolaris® from three new commercial health plans including one of the top five national providers of health insurance.

June 15, 2020
·
6 min read
Pharm Country

VASCEPA® (icosapent ethyl) Shows Significant Cardiovascular Risk Reduction in People with Diabetes in Prespecified and Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study

Primary composite first and total major adverse cardiovascular event (MACE) reductions of 23% each shown with VASCEPA in prespecified tertiary and post hoc exploratory analyses of the subgroup of people with diabetes

June 15, 2020
·
16 min read